Essential Human Virology. This item is unavailable.Essential Human Virology

*Textbook and Academic Authors Association (TAA) Textbook Excellence Award Winner, 2024*

Essential Human Virology, Second Edition focuses on the structure and classification of viruses, virus transmission and virus replication strategies based upon type of viral nucleic acid. Several chapters focus on notable and recognizable viruses and the diseases caused by them, including influenza, HIV, hepatitis viruses, poliovirus, herpesviruses and emerging and dangerous viruses. Additionally, how viruses cause disease (pathogenesis) is highlighted, along with discussions on immune response to viruses, vaccines, anti-viral drugs, gene therapy, the beneficial uses of viruses, research laboratory assays and viral diagnosis assays.

Fully revised and updated with new chapters on coronaviruses, nonliving infectious agents, and notable non-human viruses, the book provides students with a solid foundation in virology.

• Focuses on human diseases and the cellular pathology that viruses cause
• Highlights current and cutting-edge technology and associated issues
• Presents real case studies and current news highlights in each chapter
• Features dynamic illustrations, chapter assessment questions, key terms, and a summary of concepts, as well as an instructor website with lecture slides, a test bank and recommended activities
• Updated and revised, with new chapters on coronaviruses, nonliving infectious agents, and notable non-human viruses

Jennifer Louten is currently a Professor of Biology at Kennesaw State University in Georgia, USA. She has served as a Teaching Fellow and has developed courses in virology, biotechnology, immunology, and cell culture techniques. She is the recipient of an Outstanding Teaching Award, Outstanding Early Career Faculty Award, and the Student Government Association’s Faculty of the Year Award. She received her Ph.D. from Brown University Medical School, where she investigated the cellular targets of infection and the induction of type 1 interferons following infection with lymphocytic choriomeningitis virus. Before joining academia, Dr. Louten performed research in drug discovery at Schering-Plough Biopharma (currently Merck Research Laboratories). She received her Bachelor of Science in biotechnology from the Rochester Institute of Technology.